[go: up one dir, main page]

CS261883B2 - Method of new substituted pyrrolidinones production - Google Patents

Method of new substituted pyrrolidinones production Download PDF

Info

Publication number
CS261883B2
CS261883B2 CS853854A CS385485A CS261883B2 CS 261883 B2 CS261883 B2 CS 261883B2 CS 853854 A CS853854 A CS 853854A CS 385485 A CS385485 A CS 385485A CS 261883 B2 CS261883 B2 CS 261883B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
group
phenyl
carbon atoms
benzylpyrrolidin
Prior art date
Application number
CS853854A
Other languages
Czech (cs)
English (en)
Other versions
CS385485A2 (en
Inventor
Karl-Heinz Dr Weber
Claus Dr Schneider
Gerhard Dr Walther
Dieter Prof Dr Hinzen
Franz Josef Dr Kuhn
Erich Dr Lehr
Helmut Dr Ensinger
Wolfgang Dr Troger
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of CS385485A2 publication Critical patent/CS385485A2/cs
Publication of CS261883B2 publication Critical patent/CS261883B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS853854A 1984-05-30 1985-05-29 Method of new substituted pyrrolidinones production CS261883B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843420193 DE3420193A1 (de) 1984-05-30 1984-05-30 Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Publications (2)

Publication Number Publication Date
CS385485A2 CS385485A2 (en) 1988-06-15
CS261883B2 true CS261883B2 (en) 1989-02-10

Family

ID=6237240

Family Applications (1)

Application Number Title Priority Date Filing Date
CS853854A CS261883B2 (en) 1984-05-30 1985-05-29 Method of new substituted pyrrolidinones production

Country Status (22)

Country Link
US (4) US4670456A (fi)
EP (1) EP0163260B1 (fi)
JP (1) JPS6168A (fi)
KR (1) KR850008343A (fi)
AT (1) ATE36151T1 (fi)
AU (1) AU581438B2 (fi)
CA (1) CA1255664A (fi)
CS (1) CS261883B2 (fi)
DD (1) DD235256A5 (fi)
DE (2) DE3420193A1 (fi)
DK (1) DK239685A (fi)
ES (4) ES8607926A1 (fi)
FI (1) FI78462C (fi)
GR (1) GR851306B (fi)
HU (1) HU193393B (fi)
IL (1) IL75339A (fi)
NO (1) NO852133L (fi)
NZ (1) NZ212241A (fi)
PL (1) PL144921B1 (fi)
PT (1) PT80545B (fi)
SU (1) SU1360583A3 (fi)
ZA (1) ZA854072B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
FR2597100A1 (fr) * 1986-01-21 1987-10-16 Nippon Shinyaku Co Ltd Derives du pyroglutamide
US4960776A (en) * 1987-01-28 1990-10-02 A. H. Robins Company, Inc. 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
US4833139A (en) * 1988-01-25 1989-05-23 Hoechst-Roussel Pharmaceuticals, Inc. Enhancing cholinergic activity with 5-substituted 1-[4-(1-pyrrolidinyl)-2-butynyl]-2-pyrrolidinones and related compounds
IE61631B1 (en) * 1988-05-20 1994-11-16 Zambon Spa Compounds with central analgesic activity, process for their preparation and pharmaceutical compositions containing them
JPH02137427A (ja) * 1988-11-18 1990-05-25 Du Pont Opt Electron Kk 光電気的接続装置及び光コンセント
US4981974A (en) * 1989-05-08 1991-01-01 Gaf Chemicals Corporation Polymerizable pyrrolidonyl oxazoline monomers
DK2383271T3 (da) * 2006-03-13 2013-10-07 Kyorin Seiyaku Kk Aminoquinoloner som GSK-3-inhibitorer
KR101563018B1 (ko) * 2007-09-11 2015-10-23 교린 세이야꾸 가부시키 가이샤 Ｇｓｋ-３ 억제제로서의 시아노아미노퀴놀론 및 테트라졸로아미노퀴놀론
KR20100096222A (ko) 2007-12-05 2010-09-01 아스트라제네카 아베 피페라진 유도체 및 렙틴 수용체 조절물질로서 그 유도체의 용도
US7851471B2 (en) * 2007-12-05 2010-12-14 Astrazeneca Ab (Publ) Compounds I
BRPI0913450A2 (pt) * 2008-06-04 2015-12-01 Astrazeneca Ab composto, formulação farmacêutica, uso de um composto, e, método para tratamento ou prevenção de condições ou doenças e para inibição de angiogênese
KR101748891B1 (ko) * 2009-03-11 2017-06-19 교린 세이야꾸 가부시키 가이샤 Ｇｓｋ-3 억제제로서의 7-시클로알킬아미노퀴놀론

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2838914A (en) * 1957-07-03 1958-06-17 Olin Mathieson Isonicotinic acid hydrazide derivatives
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
JPS4924916B1 (fi) * 1970-08-14 1974-06-26
FR2387218A1 (fr) * 1977-04-15 1978-11-10 Ile De France Nouveaux n-(1'-ethyl 2'-oxo 5'-pyrrolidinyl methyl) benzamides, leurs procedes de preparation et leur application comme modificateurs du comportement
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
GB8412358D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
US4670436A (en) * 1986-08-29 1987-06-02 Mcneilab, Inc. Hypoglycemic 5-substituted pyrrolidinylidene compounds, compositions and use

Also Published As

Publication number Publication date
ES8607926A1 (es) 1986-06-01
PT80545B (de) 1987-04-06
PL253668A1 (en) 1986-05-20
DD235256A5 (de) 1986-04-30
HU193393B (en) 1987-09-28
FI78462B (fi) 1989-04-28
AU4317085A (en) 1985-12-05
ES543592A0 (es) 1986-06-01
ES552409A0 (es) 1987-12-16
HUT37751A (en) 1986-02-28
US4857528A (en) 1989-08-15
KR850008343A (ko) 1985-12-16
ATE36151T1 (de) 1988-08-15
DK239685D0 (da) 1985-05-29
IL75339A0 (en) 1985-09-29
GR851306B (fi) 1985-11-25
ES8707927A1 (es) 1987-09-01
FI852130L (fi) 1985-12-01
ZA854072B (en) 1987-02-25
SU1360583A3 (ru) 1987-12-15
FI852130A0 (fi) 1985-05-29
NZ212241A (en) 1989-07-27
US4670456A (en) 1987-06-02
IL75339A (en) 1988-07-31
PL144921B1 (en) 1988-07-30
JPH0517904B2 (fi) 1993-03-10
ES552410A0 (es) 1987-09-01
FI78462C (fi) 1989-08-10
CA1255664A (en) 1989-06-13
DE3420193A1 (de) 1985-12-05
JPS6168A (ja) 1986-01-06
EP0163260B1 (de) 1988-08-03
ES8801200A1 (es) 1987-12-16
EP0163260A1 (de) 1985-12-04
DE3564105D1 (en) 1988-09-08
US4762832A (en) 1988-08-09
DK239685A (da) 1985-12-01
ES552411A0 (es) 1987-09-01
AU581438B2 (en) 1989-02-23
US4891378A (en) 1990-01-02
NO852133L (no) 1985-12-02
CS385485A2 (en) 1988-06-15
PT80545A (de) 1985-06-01
ES8707928A1 (es) 1987-09-01

Similar Documents

Publication Publication Date Title
DE3514076C2 (fi)
CS244148B2 (en) Method of aminomethylpyrrolidine production
EP0153277B1 (de) Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
CS261883B2 (en) Method of new substituted pyrrolidinones production
EP0528922B1 (de) Neue sulfonylverbindungen
DE60022227T2 (de) 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung
DE2708236A1 (de) 3-aryl-2-oxazolidinone, verfahren zu ihrer herstellung und arzneimittel
EP0053744A1 (de) Neue 8-Arylalkyl-3-phenyl-3-nortropanole, deren Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE2311570A1 (de) 4-aminochinoline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
CH675418A5 (fi)
DE3216843C2 (de) 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH615914A5 (fi)
DE2211738A1 (de) Pyrimidinylpiperazine und Verfahren zu deren Herstellung
EP0298921B1 (de) 1,2-Benzisoxazole und 1,2-Benzisothiazole
EP0266308B1 (de) Indolo-pyrazino-benzodiazepin-Derivate
CH651554A5 (de) Schwefelhaltige isochinolinderivate, verfahren zur herstellung derselben und die diese verbindungen enthaltenden pharmazeutischen zubereitungen.
DE69009715T2 (de) Azabicycloamide und -ester als 5-HT3-Receptor-Antagonisten.
EP0088323A2 (de) Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
EP0462150B1 (de) Neue aryloxy-alkylamine, deren herstellung und diese enthaltende arzneimittel
LU82823A1 (de) Neue 1,2,4-oxadiazin-derivate,ihre herstellung,bei ihrer herstellung anwendbare zwischenprodukte sowie pharmazeutische mittel
AT334892B (de) Verfahren zur herstellung neuer alfa,alfa-diarylimidazol-2-methanole und deren salze
CS244144B2 (cs) Způsob výroby aminomethylpyrrolidinonů
CH644378A5 (de) Pyrido(3,4-e)-as-triazin-derivate und verfahren zu deren herstellung.
JPS62252762A (ja) ピログルタミド誘導体
EP0198227A2 (de) Imidazo-Isochinoline und Imidazo-Thienopyridin-Verbindungen, Arzneimittel enthaltend diese Verbindungen und Verfahren zu ihrer Herstellung